These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 22414757

  • 1. Alkyl cinnamates as regulator for the C1 domain of protein kinase C isoforms.
    Mamidi N, Gorai S, Sahoo J, Manna D.
    Chem Phys Lipids; 2012 Apr; 165(3):320-30. PubMed ID: 22414757
    [Abstract] [Full Text] [Related]

  • 2. Development of diacyltetrol lipids as activators for the C1 domain of protein kinase C.
    Mamidi N, Gorai S, Mukherjee R, Manna D.
    Mol Biosyst; 2012 Apr; 8(4):1275-85. PubMed ID: 22301880
    [Abstract] [Full Text] [Related]

  • 3. Binding of isoxazole and pyrazole derivatives of curcumin with the activator binding domain of novel protein kinase C.
    Das J, Pany S, Panchal S, Majhi A, Rahman GM.
    Bioorg Med Chem; 2011 Nov 01; 19(21):6196-202. PubMed ID: 21975067
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and protein kinase C (PKC)-C1 domain binding properties of diacyltetrol based anionic lipids.
    Mamidi N, Panda S, Borah R, Manna D.
    Mol Biosyst; 2014 Nov 01; 10(11):3002-13. PubMed ID: 25190464
    [Abstract] [Full Text] [Related]

  • 5. Selective binding of phorbol esters and diacylglycerol by individual C1 domains of the PKD family.
    Chen J, Deng F, Li J, Wang QJ.
    Biochem J; 2008 Apr 15; 411(2):333-42. PubMed ID: 18076381
    [Abstract] [Full Text] [Related]

  • 6. Activation mechanisms of conventional protein kinase C isoforms are determined by the ligand affinity and conformational flexibility of their C1 domains.
    Ananthanarayanan B, Stahelin RV, Digman MA, Cho W.
    J Biol Chem; 2003 Nov 21; 278(47):46886-94. PubMed ID: 12954613
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Molecular modeling and site-directed mutagenesis studies of a phorbol ester-binding site in protein kinase C.
    Wang S, Kazanietz MG, Blumberg PM, Marquez VE, Milne GW.
    J Med Chem; 1996 Jun 21; 39(13):2541-53. PubMed ID: 8691452
    [Abstract] [Full Text] [Related]

  • 9. Structure of the C2 domain from novel protein kinase Cepsilon. A membrane binding model for Ca(2+)-independent C2 domains.
    Ochoa WF, Garcia-Garcia J, Fita I, Corbalan-Garcia S, Verdaguer N, Gomez-Fernandez JC.
    J Mol Biol; 2001 Aug 24; 311(4):837-49. PubMed ID: 11518534
    [Abstract] [Full Text] [Related]

  • 10. A new mechanism of action of a C2 domain-derived novel PKC inhibitor peptide.
    Farah CA, Sossin WS.
    Neurosci Lett; 2011 Oct 31; 504(3):306-10. PubMed ID: 21982802
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ligand structure-activity requirements and phospholipid dependence for the binding of phorbol esters to protein kinase D.
    Wang QJ, Fang TW, Yang D, Lewin NE, Van Lint J, Marquez VE, Blumberg PM.
    Mol Pharmacol; 2003 Dec 31; 64(6):1342-8. PubMed ID: 14645664
    [Abstract] [Full Text] [Related]

  • 13. Modeling studies on the structural determinants for the DAG/phorbol ester binding to C1 domain.
    Rahman GM, Das J.
    J Biomol Struct Dyn; 2015 Dec 31; 33(1):219-32. PubMed ID: 24666138
    [Abstract] [Full Text] [Related]

  • 14. Differential selectivity of ligands for the C1a and C1b phorbol ester binding domains of protein kinase Cdelta: possible correlation with tumor-promoting activity.
    Bögi K, Lorenzo PS, Szállási Z, Acs P, Wagner GS, Blumberg PM.
    Cancer Res; 1998 Apr 01; 58(7):1423-8. PubMed ID: 9537243
    [Abstract] [Full Text] [Related]

  • 15. The C1B domains of novel PKCε and PKCη have a higher membrane binding affinity than those of the also novel PKCδ and PKCθ.
    Egea-Jiménez AL, Corbalán-García S, Gómez-Fernández JC.
    Biochim Biophys Acta; 2014 Jul 01; 1838(7):1898-909. PubMed ID: 24732301
    [Abstract] [Full Text] [Related]

  • 16. Effects on ligand interaction and membrane translocation of the positively charged arginine residues situated along the C1 domain binding cleft in the atypical protein kinase C isoforms.
    Pu Y, Peach ML, Garfield SH, Wincovitch S, Marquez VE, Blumberg PM.
    J Biol Chem; 2006 Nov 03; 281(44):33773-88. PubMed ID: 16950780
    [Abstract] [Full Text] [Related]

  • 17. Design and physicochemical properties of new fluorescent ligands of protein kinase C isozymes focused on CH/pi interaction.
    Sugimoto T, Itagaki K, Irie K.
    Bioorg Med Chem; 2008 Jan 15; 16(2):650-7. PubMed ID: 17977729
    [Abstract] [Full Text] [Related]

  • 18. Structural basis of RasGRP binding to high-affinity PKC ligands.
    Rong SB, Enyedy IJ, Qiao L, Zhao L, Ma D, Pearce LL, Lorenzo PS, Stone JC, Blumberg PM, Wang S, Kozikowski AP.
    J Med Chem; 2002 Feb 14; 45(4):853-60. PubMed ID: 11831896
    [Abstract] [Full Text] [Related]

  • 19. Effects of ortho substituent groups of protocatechualdehyde derivatives on binding to the C1 domain of novel protein kinase C.
    Mamidi N, Borah R, Sinha N, Jana C, Manna D.
    J Phys Chem B; 2012 Sep 06; 116(35):10684-92. PubMed ID: 22861150
    [Abstract] [Full Text] [Related]

  • 20. Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR).
    Zhou M, Horita DA, Waugh DS, Byrd RA, Morrison DK.
    J Mol Biol; 2002 Jan 18; 315(3):435-46. PubMed ID: 11786023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.